Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa (Q39894808)

15 September 2017

Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa (English)

1 reference

15 September 2017

0 references

Pseudomonas aeruginosa

0 references

multiple drug resistance

1 reference

Nobumasa Aoki

1

1 reference

15 September 2017

Kazuhiro Tateda

2

1 reference

15 September 2017

Yoshiaki Kikuchi

3

1 reference

15 September 2017

Soichiro Kimura

4

1 reference

15 September 2017

Choichiroh Miyazaki

5

1 reference

15 September 2017

Yoshikazu Ishii

6

1 reference

15 September 2017

Yoshinari Tanabe

7

1 reference

15 September 2017

Fumitake Gejyo

8

1 reference

15 September 2017

Keizo Yamaguchi

9

1 reference

15 September 2017

language of work or name

English

0 references

publication date

14 January 2009

1 reference

Journal of Antimicrobial Chemotherapy

15 September 2017

1 reference

15 September 2017

63

1 reference

15 September 2017

534-542

1 reference

15 September 2017

3

1 reference

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

15 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

Ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

A reassessment of the in-vitro activity of colistin sulphomethate sodium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

In vitro activity of the aerosolized agents colistin and tobramycin and five intravenous agents against Pseudomonas aeruginosa isolated from cystic fibrosis patients in southwestern Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

Solution structure of polymyxins B and E and effect of binding to lipopolysaccharide: an NMR and molecular modeling study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

Binding and neutralization of bacterial lipopolysaccharide by colistin nonapeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

Methods of testing combined antibiotic bactericidal action and the significance of the results

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

Antimicrobial-induced release of endotoxin from Pseudomonas aeruginosa: comparison of in vitro and animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

The utility of diffusion chambers as models for the description of drug disposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

Development of a novel assay method for colistin sulphomethate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

A pharmacokinetic analysis program (multi) for microcomputer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

Statistical moments in pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

Efficacy of colistin versus beta-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

Effect of aerosolized colistin on multidrug-resistant Pseudomonas aeruginosa in bronchial secretions of patients without cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

In vitro effects of combinations of antipseudomonal agents against seven strains of multidrug-resistant Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

The comparison of in the vitro effect of imipenem or meropenem combined with ciprofloxacin or levofloxacin against multidrug-resistant Pseudomonas aeruginosa strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

Effects of blood pressure lowering in the acute phase of total anterior circulation infarcts and other stroke subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

Microbiological activity and clinical efficacy of a colistin and rifampin combination in multidrug-resistant Pseudomonas aeruginosa infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

Lipopolysaccharide antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

Aerosolised antibacterials for the prevention and treatment of hospital-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN530

21 January 2018

Identifiers

DOI

10.1093/JAC/DKN530

1 reference

15 September 2017

1 reference